Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Cello Health PLC

10 Aug 2020 11:02

RNS Number : 6575V
Puma Investment Management Limited
10 August 2020
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Puma Investment Management Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Cello Health Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

07/08/2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES / NO / N/A

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Cello Health Plc Ord Gbp0.10

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,426,647

1.33%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

1,426,647

1.33%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Cello Health Plc Ord Gbp0.10

Sale

3632

 

£1.61

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES/NO

 

 

Date of disclosure:

10/08/2020

Contact name:

Rachel Stansfield

(email: rachel.stansfield@pumainvestments.co.uk)

Telephone number*:

d:m:

+44 (0)20 7468 7966+44 (0)79 7036 2154

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETKZGMRLGLGGZG
Date   Source Headline
29th Jun 20077:01 amRNSDirector/PDMR Shareholding
28th Jun 20077:01 amRNSDirectorate Change
8th Jun 20077:01 amRNSAcquisition
22nd May 20071:00 pmRNSAGM Statement
16th May 20079:43 amRNSShare Option Grants
1st May 20074:15 pmRNSAnnual Report and Accounts
1st May 20074:13 pmRNSShare Option Grants
27th Apr 200712:41 pmRNSDirector/PDMR Shareholding
26th Apr 20077:01 amRNSInvestment
10th Apr 20079:44 amRNSTotal voting rights update
2nd Apr 20073:48 pmRNSDirector/PDMR Shareholding
30th Mar 20077:01 amRNSAcquisition
29th Mar 20072:07 pmRNSHolding(s) in Company
20th Mar 20077:01 amRNSFinal Results
9th Mar 20071:18 pmRNSHolding(s) in Company
28th Feb 20074:53 pmRNSHolding(s) in Company
19th Feb 200711:14 amRNSNotice of Results
2nd Feb 20073:05 pmRNSTotal Voting Rights
29th Jan 20077:01 amRNSAcquisition
19th Jan 20073:19 pmRNSHolding(s) in Company
11th Jan 20077:01 amRNSPre Close Trading Statement
15th Dec 20069:01 amRNSDirector/PDMR Shareholding
12th Dec 20069:00 amRNSTotal Voting Rights
30th Nov 20063:56 pmRNSHolding(s) in Company
13th Nov 200612:48 pmRNSAnalyst/Investor Presentation
5th Oct 20065:10 pmRNSNotifiable Interest
4th Oct 20063:53 pmRNSHolding(s) in Company
26th Sep 20067:03 amRNSAcquisition
11th Sep 20063:58 pmRNSHolding(s) in Company
5th Sep 20067:02 amRNSInvestment in Digital Agency
5th Sep 20067:02 amRNSInterim Results
17th Aug 20069:54 amRNSNotice of Results
26th Jul 20062:17 pmRNSAdditional Listing
3rd Jul 200611:53 amRNSAdditional Listing
3rd Jul 20067:01 amRNSPre Close Trading Statement
3rd Jul 20067:01 amRNSControlling Stake
26th Jun 20063:23 pmRNSInvest in brand consulting op
26th Jun 20067:19 amRNSAcquisition
21st Jun 200612:15 pmRNSAnnual Report and Accounts
19th Jun 20063:22 pmRNSMajor Interest in Shares
23rd May 200612:58 pmRNSAGM Statement
27th Mar 20065:46 pmRNSMajor Interest in Shares
27th Mar 20065:05 pmRNSMajor Interests in Shares
21st Mar 20063:39 pmRNSHolding(s) in Company
16th Mar 20067:00 amRNSPerformance Share Option Plan
15th Mar 20067:01 amRNSDirector/PDMR Shareholding
14th Mar 20067:05 amRNSShare Option Plan
14th Mar 20067:02 amRNSFinal Results
20th Feb 20065:19 pmRNSNotice of Results
25th Jan 20063:11 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.